hfpef semaglutide STEP Sub Studies Whiteboard Semaglutide versus placebo in patients

Will GLP-1 medications worsen my thyroid antibodies

By inhibiting NNMT, 5-Amino-1MQ appears to improve how the body handles glucose

Quality and Sourcing Considerations Product quality represents perhaps the most significant variable affecting BPC-157 outcomes

Eli Lilly's Retatrutide Advances Toward FDA Submission A major milestone in obesity treatment as Retatrutide (LY3437943) continues to demonstrate impressive Phase 3 results

On Pfizers post-deal call, they alluded to having seen some of Metseras forthcoming VESPER-3 data disclosure, which reinforced confidence in MET-097i differentiated profile

Conversations that Count: ART for People Living with HIV Available for free access, this CPE podcast episode offers actionable steps to fostering trust and patient ownership throughout the antiretroviral therapy (ART) journey for people living with HIV